Athersys to Host Shareholder Conference Call CLEVELAND,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Athersys to Host Shareholder Conference Call

CLEVELAND, April 24, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX ) announced today that it will be hosting a shareholder conference call on Wednesday, April 29, 2015 to present the recently announced interim results of its exploratory Phase 2 clinical study of the intravenous administration of MultiStem ® cell therapy to treat patients who have suffered an ischemic stroke.

The conference call will begin at 2:00 PM EDT and will be hosted by Dr. Gil Van Bokkelen, Chairman and Chief Executive Officer of Athersys. Joining Dr. Van Bokkelen on the call will be Dr. David Hess, stroke specialist and Chairman of the Department of Neurology at the Medical College of Georgia at Georgia Regents University, and Dr. Lawrence Wechsler, Professor of Neurology and Chair of the Department of Neurology at the University of Pittsburgh. Both Drs. Hess and Wechsler are clinical investigators for the study and are recognized as independent experts and key opinion leaders in the field of stroke treatment.

Athersys will host the call as follows:

 
Date April 29, 2015
Time 2:00 p.m. (Eastern Time)
Telephone access: US and Canada 800-273-1254
Telephone access: International 973-638-3440
Access code 35326665
Live webcast www.athersys.com under Investors section

A replay will be available for on-demand listening shortly after the completion of the call until 11:59 PM EDT on May 13, 2015 at the aforementioned URL, or by dialing 800-585-8367 or 855-859-2056 in the U.S. and Canada, or from abroad 404-537-3406, and entering access code 35326665.

About Athersys

Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem ® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and collaborations with leading pharmaceutical and biotechnology companies, as well as world-renowned research institutions to further develop its platform and products. More information is available at www.athersys.com .

William (B.J.) Lehmann, J.D. President and Chief Operating Officer Tel: (216) 431-9900

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BASIS Bellevue Expands with New K-4 Campus

Updated Category News Views 89

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Continue Reading
Yellow River Basin Firms Focus on Global Expansion

Updated Category News Views 58

Shandong's Bold Move on the Global Stage Imagine the bustling city of Jinan, Shandong's capital, humming with the energy of ambitious enterprises ready to leap into the global arena. That's exactly what unfolded at the conference aimed at forging international ties under the Belt and Road Initiative (BRI). For those out of the loop, this ain't just another business...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 73

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading
Smirnoff Launches Marvel Event with $12.99 Offer

Updated Category News Views 114

Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...

Continue Reading
Markel Stays the Course: Solid Q3 Results in 2026

Updated Category News Views 141

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

Continue Reading
JumpCloud Tackles Compliance in the AI Era

Updated Category News Views 110

Compliance in a Changing Tech Landscape JumpCloud's stepping up in this brave new world riddled with tech and AI agents. They've got fresh platform features in their arsenal that'll keep organizations audit-ready day in and day out. Now, if you think compliance is just for the accountants to fret over, think again. In the agentic era, these advanced marvels—AI agents...

Continue Reading
Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

Updated Category News Views 111

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Continue Reading
Jamaica's Tourism Rebounds Post-Hurricane Challenges

Updated Category News Views 128

Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...

Continue Reading
Aker BP's Q3 2026: Strong Earnings Fuel Optimism

Updated Category News Views 25

Third Quarter Overview: Riding the Wave Aker BP's third quarter report is a raucous symphony of successes that have the market nodding in admiration. Marking significant strides with their offshore projects, the company seems to be in a cavalier mood as it boasts higher sales volumes and promising financials. Net production came in at 374 mboepd, dampened slightly by...

Continue Reading
Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 112

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women in HVACR: Join the 2025 Convention

Updated Category News Views 247

Women in HVACR Announces Annual Convention The nonprofit organization is now accepting registrations for an upcoming conference aimed at empowering women in the HVACR industry. Details About the Conference Women in HVACR (WHVACR) has confirmed that it will host its annual conference at the Red Rock Casino, Resort & Spa. Registration is currently open, inviting...

Continue Reading
Exploring Growth in the Global Personalized Gifts Industry

Updated Category News Views 191

Overview of the Personalized Gifts Market In today's world, the personalized gifts market is on the verge of a significant expansion, projected to increase by USD 10.76 billion by 2029. This remarkable growth results from various factors, including advancements in technology and changing consumer preferences. More than ever, people value unique and heartwarming gifts that...

Continue Reading
Cellectar Biosciences Sees Growth Amid Drug Development Advances

Updated Category News Views 252

Cellectar Biosciences Financial Performance and Recent Developments Cellectar Biosciences, Inc. (NASDAQ: CLRB), a biopharmaceutical company dedicated to cancer treatment, has announced its financial results for the year ending December 31, 2024. As it advances towards new treatment protocols and expands into clinical trials, the firm reveals a positive outlook for growth....

Continue Reading
Fair Play Menarini: Celebrating 30 Years in Florence

Updated Category News Views 11

Honoring Athletes with Integrity In this fast-paced world of competitive sports, it's easy to get lost in the glitz and glamour, the medals, the money, the fame—heck, even the scandals. Yet, there's an award out there tipping its hat to those who've kept their heads straight and their hearts clean, come hell or high water. We had ourselves a real humdinger of a night in...

Continue Reading
Vidu Unveils Innovative AI Technology to Transform Photography

Updated Category News Views 350

Vidu Revamps the Photography Landscape with AI Innovation ShengShu Technology presents Vidu's groundbreaking Reference-to-Image feature, primed to transform our understanding of photography. This innovative image compositing tool offers a unique capability to generate lifelike photographs from a collection of seven reference images, while ensuring the utmost consistency...

Continue Reading
reckenridge Launches Everolimus Tablets to Enhance Patient Care"> Continue Reading